Status:
UNKNOWN
Deep Inspiration Breath-hold Radiotherapy for Left-sided Breast Cancer
Lead Sponsor:
Shu lian Wang
Conditions:
Breast Cancer
Cardiac Event
Eligibility:
FEMALE
18-70 years
Brief Summary
Postoperative breast radiotherapy (RT) has been associated with increased risk of heart toxicity. However, there is a lack of knowledge for radiation-induced early cardiovascular injury, especially fo...
Detailed Description
Women with left-sided breast cancer undergo hypofractionated RT at either free-breathing or deep inspiration breath-hold. The incidence and potential clinical, dosimetric and biological indicators of ...
Eligibility Criteria
Inclusion
- Primary left-sided breast cancer post surgery
- Planning for adjuvant breast/chest wall +-RNI
Exclusion
- History of cardiovascular disease
- Previous chest radiation
- Bilateral breast cancers
Key Trial Info
Start Date :
September 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2023
Estimated Enrollment :
166 Patients enrolled
Trial Details
Trial ID
NCT05200078
Start Date
September 1 2021
End Date
June 30 2023
Last Update
January 20 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cancer Hospital, Chinese Academy of Medical Sciences
Beijing, China, 100021